ask="100.00"
ask_size="200"
average_daily_volume="547382"
bid="N/A"
bid_size="N/A"
book_value="11.38"
change="+0.23"
change_from_200_day_moving_average="4.79"
change_from_50_day_moving_average="2.16"
change_from_52_week_high="-12.66"
change_From_52_week_low="27.59"
change_in_percent="+0.31%"
close="74.11"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.88"
ebitda="-230.87M"
eps_estimate_current_year="-6.14"
eps_estimate_next_quarter="-1.68"
eps_estimate_next_year="-6.72"
ex_dividend_date="N/A"
float_shares="37661000"
high="74.75"
high_52_weeks="86.77"
last_trade_date="2/3/2017"
last_trade_price="74.11"
last_trade_size="23042"
last_trade_time="4:00pm"
low="73.72"
low_52_weeks="46.52"
market_capitalization="3.03B"
moving_average_200_day="69.32"
moving_average_50_day="71.95"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="92.73"
open="74.49"
pe_ratio="N/A"
peg_ratio="-0.40"
percent_change_from_200_day_moving_average="+6.91%"
percent_change_from_50_day_moving_average="+3.01%"
percent_change_from_52_week_high="-14.59%"
percent_change_from_52_week_low="+59.31%"
previous_close="73.88"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.49"
price_per_sales="23583.30"
revenue="128000.00"
shares_outstanding="40859000"
short_ratio="12.30"
stock_exchange="NMS"
symbol="RARE"
volume="485622"
weeks_range_52="46.52 - 86.77"
